PLSE Stock Analysis: Buy, Sell, or Hold?
PLSE - Pulse Biosciences, Inc Common Stock (DE)
$20.60
0.97 (4.94%)
▲
5d:
-3.24%
30d:
+9.28%
90d:
+45.58%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
PLSE is down 6.9% this week, but smart money is accumulating calls. Top strike: $25 2026-05-15 with 1 OI. Call ratio: 100% View Scanner →
Strength: 8.5/10
Get Alerted When PLSE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PLSE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PLSE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: PLSE is currently trading at $20.60, which is considered fair relative to its 30-day fair value range of $18.80 to $21.75.
Technical Outlook: Technically, PLSE is in a strong uptrend. Immediate support is located at $19.52, while resistance sits at $23.18. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (6th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $22.00 (+12.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PLSE is in a strong uptrend. Immediate support is located at $19.52, while resistance sits at $23.18. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (6th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $22.00 (+12.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$18.80 -
$21.75
Company Quality Score
58/100
(HOLD)
Options IV Signal
6th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
82.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 6th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.9%)
- BULLISH: Trading below Wall St target ($22.00)
Fair Price Analysis
30-Day Fair Range
$18.80 -
$21.75
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$3.65
(17.7%)
Support & Resistance Levels
Support Level
$19.52
Resistance Level
$23.18
Current Trend
Strong Uptrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.83
Wall Street Target
$22.00
(+12.1%)
Share & Embed Analysis
Last updated: March 31, 2026 12:38 PM ET
Data refreshes hourly during market hours. Next update: 1:38 PM
Data refreshes hourly during market hours. Next update: 1:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PLSE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Patrick Danahy
SELL
5000 shares
2026-02-18
Kevin Patrick Danahy
SELL
20000 shares
2026-02-17
Kevin Patrick Danahy
SELL
20000 shares
2026-02-13
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 55 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 57 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 63 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$11 | 61 BUY |
